Ceftazidime Injection shortage
To Be Discontinued 2 presentations · 1 manufacturers · first FDA posting Nov 14, 2025 · last update Nov 14, 2025
Manufacturers: Hospira, Inc., a Pfizer Company
Stated reasons (per FDA): Not stated
More info: FDA Drug Shortages Database · ASHP drug shortages list (search there for this drug)
Presentations
| Presentation | Manufacturer | Status | Reason | Notes (FDA) | Dates |
|---|---|---|---|---|---|
| Tazicef, Injection, 1 g (NDC 0409-5092-16) | Hospira, Inc., a Pfizer Company | To Be Discontinued | — | Discontinuation of the manufacture of the drug | Posted Nov 14, 2025 Updated Nov 14, 2025 Discontinued Nov 14, 2025 |
| Tazicef, Injection, 2 g (NDC 0409-5093-11) | Hospira, Inc., a Pfizer Company | To Be Discontinued | — | Discontinuation of the manufacture of the drug | Posted Nov 14, 2025 Updated Nov 14, 2025 Discontinued Nov 14, 2025 |